Locomotion status and costs in destructive rheumatoid arthritis. A comprehensive study of 82 patients from a population of 13,000.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Acta Orthopaedica Scandinavica

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/17453679209154825PMID 1590060
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rheumatoid arthritis evaluated by locomotion score. A population study.

  1990cited by this paper
• Locomotion score in rheumatoid arthritis.

  1989cited by this paper
• A multicenter study of annual health service utilization and costs in rheumatoid arthritis.

  1986cited by this paper
• Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years.

  1984cited by this paper
• The lifetime economic costs of rheumatoid arthritis.

  1984cited by this paper
• The lifetime economic costs of rheumatoid arthritis.

  1984cited by this paper
• The costs of rheumatoid arthritis. A patient-oriented study of chronic disease costs.

  1978cited by this paper
• The Epidemiology of Chronic Rheumatism

  1964cited by this paper

• SOCIAL SIGNIFICANCE AND ECONOMIC CONSEQUENCES OF RHEUMATIC DISEASES

  2019cites this paper
• Direct Health Costs of Inflammatory Polyarthritis 10 Years after Disease Onset: Results from the Norfolk Arthritis Register

  2015cites this paper
• Can biologic therapies be withdrawn or tapered in psoriatic arthritis?

  2013cites this paper
• Scleritis: Immunopathogenesis and molecular basis for therapy.

  2013cites this paper
• Epidemiology and burden of illness of rheumatoid arthritis

  2012cites this paper
• Economic Burden of Psoriatic Arthritis

  2012cites this paper
• An Overview of Economic Evaluations for Drugs Used in Rheumatoid Arthritis

  2012cites this paper
• The Burden of Arthritis and Nonsteroidal Anti-Inflammatory Treatment

  2012cites this paper
• The Underestimated Long Term Medical and Economic Consequences of Rheumatoid Arthritis

  2012cites this paper
• International variation in resource utilisation and treatment costs for rheumatoid arthritis

  2012cites this paper
• Cost of rheumatoid arthritis in a selected population from Argentina in the prebiologic therapy era

  2012cites this paper
• Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

  2011cites this paper
• Work Capacity and Productivity Costs in Early Rheumatoid Arthritis: A Five-year Prospective Study

  2009cites this paper
• Cost-Effectiveness of New Biologics for Rheumatoid Arthritis and Osteoarthritis

  2008cites this paper
• Artritis reumatoide: ¿cuán cara es?

  2007cites this paper
• Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany

  2006cites this paper
• Disease activity, function and costs in early rheumatoid arthritis

  2006cites this paper
• Extent of occupational hand use among persons with rheumatoid arthritis.

  2006cites this paper
• Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

  2006cites this paper
• Artritis reumatoide (I). Etiopatogenia

  2005cites this paper
• Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates.

  2004cites this paper
• Rheumatoid arthritis: direct and indirect costs.

  2004cites this paper
• Polyarthrite rhumatoïde : coûts directs et indirects

  2004cites this paper
• Análisis de costes de infliximab y etanercept en el tratamiento de pacientes con artritis reumatoide en España basado en un modelo farmacoeconómico

  2004cites this paper
• Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project).

  2004cites this paper
• Development of a Matrix

  2004cites this paper
• Identification of modifiable work-related factors that influence the risk of work disability in rheumatoid arthritis.

  2004cites this paper
• Anti-CD4 monoclonal antibodies in rheumatoid arthritis

  2004cites this paper
• Repercusión socioeconómica de la artritis reumatoide

  2003cites this paper
• Principles of rheumatoid arthritis control.

  2003cites this paper
• Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries

  2002cites this paper
• A multicenter cost-of-illness study on rheumatoid arthritis in Italy.

  2002cites this paper
• Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis.

  2002cites this paper
• Total costs and predictors of costs in individuals with early inflammatory polyarthritis: a community-based prospective study.

  2002cites this paper
• Costes económicos de la artritis reumatoide de corta evolución

  2001cites this paper
• Development of a matrix of cost domains in economic evaluation of rheumatoid arthritis.

  2001cites this paper
• A national study of medical care expenditures for musculoskeletal conditions: the impact of health insurance and managed care.

  2001cites this paper
• Etanercept in rheumatoid arthritis

  2001cites this paper
• Secondary health service care and second line drug costs of early inflammatory polyarthritis in Norfolk, UK.

  2000cites this paper
• Economic burden of rheumatoid arthritis: a systematic review.

  2000influential citation
• SOCIOECONOMIC COSTS OF RHEUMATIC DISEASES

  2000cites this paper
• The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.

  1998cites this paper
• The clinical management of rheumatoid arthritis and osteoarthritis: strategies for improving clinical effectiveness.

  1998cites this paper
• The Economic Impact of Parkinson’s Disease

  1998cites this paper
• New prospects for the treatment of rheumatoid arthritis.

  1998cites this paper
• Direct cost of rheumatoid arthritis during the first six years: a cost-of-illness study.

  1998cites this paper
• The burden of rheumatoid arthritis: facts and figures.

  1998cites this paper
• Krankheitskosten der Parkinson-Erkrankung Eine retrospektive dreimonatige Analyse der direkten Kosten

  1997cites this paper
• The Costs of Rheumatoid Arthritis

  1994cites this paper
• Indirect Costs in Economic Studies

  1993cites this paper
• Indirect costs in economic studies: confronting the confusion.

  1993cites this paper
• Clinicoeconomics and Outcomes Research Dovepress Economic Evaluation of Anti-tnf Agents for Patients with Rheumatoid Arthritis in Greece

  year unknowncites this paper